Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Lucas

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Gastroenterology|September 14, 2004
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGeorg M Lauer, Eleanor Barnes, Michaela Lucas, et al.
The Journal of Clinical Investigation|September 17, 2003
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersCheryl L Day, Nilufer P Seth, Michaela Lucas, et al.
Blood|October 2, 2004
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1Arthur Y Kim, Georg M Lauer, Kei Ouchi, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Journal of Virology|November 13, 2009
Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolutionVictoria Kasprowicz, Yu-Hoi Kang, Michaela Lucas, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 6, 2026
Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health SurveyYichao Wang, Jennifer J Koplin, Janet M Davies, et al.
BMJ Open|August 25, 2025
Randomised controlled trial of a low plastic diet and lifestyle intervention for adults with cardiometabolic risk factors: the Plastic Exposure Reduction Transforms Health (PERTH) trial - a protocolAndrew Lucas, Amelia Harray, Lelinh Duong, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Gastroenterology|September 14, 2004
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGeorg M Lauer, Eleanor Barnes, Michaela Lucas, et al.
The Journal of Clinical Investigation|September 17, 2003
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersCheryl L Day, Nilufer P Seth, Michaela Lucas, et al.
Blood|October 2, 2004
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1Arthur Y Kim, Georg M Lauer, Kei Ouchi, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Journal of Virology|November 13, 2009
Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolutionVictoria Kasprowicz, Yu-Hoi Kang, Michaela Lucas, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 6, 2026
Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health SurveyYichao Wang, Jennifer J Koplin, Janet M Davies, et al.
BMJ Open|August 25, 2025
Randomised controlled trial of a low plastic diet and lifestyle intervention for adults with cardiometabolic risk factors: the Plastic Exposure Reduction Transforms Health (PERTH) trial - a protocolAndrew Lucas, Amelia Harray, Lelinh Duong, et al.
Pageof 13